GlycoMimetics Inc. [GLYC] Revenue clocked in at $10.00 million, down -24.01% YTD: What’s Next?

GlycoMimetics Inc. [NASDAQ: GLYC] stock went on an upward path that rose over 6.63% on Tuesday, amounting to a one-week price increase of more than 20.00%. The company report on November 11, 2020 that GlycoMimetics to Present at Two Upcoming Virtual Healthcare Investor Conferences.

GlycoMimetics, Inc. (Nasdaq: GLYC), announces that CEO Rachel King plans to present an overview of the company at the upcoming Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17 and the Jefferies Virtual London Healthcare Conference on Thursday, November 19. Both presentations will be available on the Company’s website, under the Investors tab. Details are as follows:.

Stifel 2020 Virtual Healthcare ConferenceNovember 16-18, 2020GlycoMimetics presentation: Tuesday, November 17, 8:00 a.m. (EST).

Over the last 12 months, GLYC stock dropped by -29.72%. The average equity rating for GLYC stock is currently 2.00, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $198.35 million, with 47.51 million shares outstanding and 46.85 million shares in the current float. Compared to the average trading volume of 373.56K shares, GLYC stock reached a trading volume of 1223385 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on GlycoMimetics Inc. [GLYC]:

ROTH Capital have made an estimate for GlycoMimetics Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 14, 2019. While these analysts kept the previous recommendation, SunTrust raised their target price from $23 to $5. The new note on the price target was released on August 05, 2019, representing the official price target for GlycoMimetics Inc. stock. Previously, the target price had yet another drop from $20 to $6, while Piper Jaffray kept a Neutral rating on GLYC stock.

The Average True Range (ATR) for GlycoMimetics Inc. is set at 0.26, with the Price to Sales ratio for GLYC stock in the period of the last 12 months amounting to 19.83. The Price to Book ratio for the last quarter was 1.38, with the Price to Cash per share for the same quarter was set at 2.90.

GLYC Stock Performance Analysis:

GlycoMimetics Inc. [GLYC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 20.00. With this latest performance, GLYC shares gained by 22.56% in over the last four-week period, additionally plugging by 26.42% over the last 6 months – not to mention a drop of -29.72% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GLYC stock in for the last two-week period is set at 68.99, with the RSI for the last a single of trading hit 75.72, and the three-weeks RSI is set at 64.30 for GlycoMimetics Inc. [GLYC]. The present Moving Average for the last 50 days of trading for this stock 3.32, while it was recorded at 3.71 for the last single week of trading, and 3.31 for the last 200 days.

Insight into GlycoMimetics Inc. Fundamentals:

Return on Total Capital for GLYC is now -33.80, given the latest momentum, and Return on Invested Capital for the company is -31.94. Return on Equity for this stock declined to -32.19, with Return on Assets sitting at -30.25. When it comes to the capital structure of this company, GlycoMimetics Inc. [GLYC] has a Total Debt to Total Equity ratio set at 2.35. Additionally, GLYC Total Debt to Total Capital is recorded at 2.30, with Total Debt to Total Assets ending up at 2.16. Long-Term Debt to Equity for the company is recorded at 1.83, with the Long-Term Debt to Total Capital now at 1.79.

Reflecting on the efficiency of the workforce at the company, GlycoMimetics Inc. [GLYC] managed to generate an average of -$1,015,648 per employee.GlycoMimetics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 14.80 and a Current Ratio set at 14.80.


With the latest financial reports released by the company, GlycoMimetics Inc. posted -0.34/share EPS, while the average EPS was predicted by analysts to be reported at -0.35/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 2.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GLYC.

GlycoMimetics Inc. [GLYC] Insider Position Details

There are presently around $160 million, or 88.70% of GLYC stock, in the hands of institutional investors. The top three institutional holders of GLYC stocks are: NEA MANAGEMENT COMPANY, LLC with ownership of 9,089,041, which is approximately 0% of the company’s market cap and around 2.04% of the total institutional ownership; BVF INC/IL, holding 7,244,262 shares of the stock with an approximate value of $29.12 million in GLYC stocks shares; and ECOR1 CAPITAL, LLC, currently with $14.97 million in GLYC stock with ownership of nearly 97.202% of the company’s market capitalization.

Positions in GlycoMimetics Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 33 institutional holders increased their position in GlycoMimetics Inc. [NASDAQ:GLYC] by around 3,111,200 shares. Additionally, 44 investors decreased positions by around 3,494,091 shares, while 18 investors held positions by with 33,111,988 shares. The mentioned changes placed institutional holdings at 39,717,279 shares, according to the latest SEC report filing. GLYC stock had 8 new institutional investments in for a total of 306,823 shares, while 14 institutional investors sold positions of 477,394 shares during the same period.

Share on facebook
Share on twitter
Share on linkedin
Share on skype
Share on reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam